Skip to main content
Fig. 2 | Cancer Nanotechnology

Fig. 2

From: A novel pH- and glutathione-responsive drug delivery system based on in situ growth of MOF199 on mesoporous organic silica nanoparticles targeting the hepatocellular carcinoma niche

Fig. 2

Hemocompatibility and cytotoxicity of different nanocomposites. A The hemolysis assays of Ultrapure water (P), PBS (N), and SPMM nanocomposites at 10 (a), 50 (b), 100 (c), 250 (d), 500 (e), and 1000 (f) dilution ratios. B Visual histogram of the hemolysis tests. Cytotoxicity tests were conducted with HepG2 by MTS assays, with incubation for 24 h (C) and 48 h (D), *p < 0.05, and **p < 0.01

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us